CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
This year’s summit provides a platform for an outstanding group of researchers, evangelists and entrepreneurs to showcase the latest advances, applications and challenges regarding the deployment of ...
CAMBRIDGE, England & EDINBURGH, Scotland & GRASSE, France--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today ...
The models can be used to plan surgeries and in the future could be used to help trial new drugs. A healthy heart beats at a steady rate, between 60 and 100 times a minute. That’s not the case for all ...
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...
With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...
LONDON - Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could potentially speed up the development of new treatments for the likes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback